Raymond James & Associates’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $344K | Sell |
|
|||||
|
2024
Q2 | $436K | Sell |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $907K | Sell |
|
|||||
|
2023
Q3 | $1.66M | Buy |
|
|||||
|
2023
Q2 | $398K | Buy |
|
|||||
|
2023
Q1 | $318K | Buy |
|
|||||
|
2022
Q4 | $311K | Buy |
|
|||||
|
2022
Q3 | $233K | Sell |
|
|||||
|
2022
Q2 | $511K | Buy |
|
|||||
|
2022
Q1 | $584K | Sell |
|
|||||
|
2021
Q4 | $681K | Sell |
|
|||||
|
2021
Q3 | $1.29M | Sell |
|
|||||
|
2021
Q2 | $1.79M | Buy |
|
|||||
|
2021
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q4 | $1.13M | Sell |
|
|||||
|
2020
Q3 | $739K | Sell |
|
|||||
|
2020
Q2 | $1.04M | Buy |
|
|||||
|
2020
Q1 | $836K | Sell |
|
|||||
|
2019
Q4 | $1.14M | Sell |
|
|||||
|
2019
Q3 | $1.04M | Buy |
|
|||||
|
2019
Q2 | $1.39M | Sell |
|
|||||
|
2019
Q1 | $2.17M | Buy |
|
|||||
|
2018
Q4 | $725K | Sell |
|
|||||
|
2018
Q3 | $1.38M | Sell |
|
|||||
|
2018
Q2 | $1.61M | Buy |
|